Status:
TERMINATED
Acute and Chronic Pain After One-stage Hybrid Arrhythmia Ablation Surgery
Lead Sponsor:
Universitair Ziekenhuis Brussel
Conditions:
Arrythmia
Chronic Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
After one-stage hybrid arrhythmia ablation surgery there are possible side effects like acute and chronic pain. There is a lot of research surrounding these pains but not specifically after one-stage ...
Eligibility Criteria
Inclusion
- 18 years of age or older
- he/she must understand and read the Dutch, French or English language
- be able to digitally agree to participate in the study
- had to have a one stage hybrid procedure at least three months ago
- have an ASA score of I, II or III.
Exclusion
- Patients with previously known chronic pain syndromes, fibromyalgia, complex regional pain syndrome are excluded.
- Subjects with previous known chronic conditions such as diabetes neuropathy, rheumatoid arthri-tis, … are also excluded.
- Subject are excluded if they underwent a surgical treatment within the observed period.
- Patients are excluded when under treatment with chemotherapy/radiotherapy
- Pregnant patients are also excluded.
- Patients with known psychological conditions such as depression are excluded.
Key Trial Info
Start Date :
February 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2025
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT05211492
Start Date
February 1 2023
End Date
June 1 2025
Last Update
December 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Brussel
Jette, Brussels Capital, Belgium, 1090